SCHEMBL7040490

SCHEMBL7040490

Cc1ccncc1-c1cc(NC(=O)N2CCc3ccccc32)c(Cl)c(C)c1C

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.55
HTR2C P28335 11/20 0.52
NPC1 O15118 3/20 0.49
NFKB1 P19838 3/20 0.49
RAB9A P51151 3/20 0.49
NFKB2 Q00653 3/20 0.49
RELA Q04206 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 2/20 0.49
PKM P14618 2/20 0.49
ROCK2 O75116 1/20 0.49
HTR2A P28223 8/20 0.48
CYP1A2 P05177 2/20 0.47
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
TP53 P04637 2/20 0.47
HTR2B P41595 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7042576 0.89 HTR2C (0.59) USP2HTR2CNPC1NFKB1RAB9A
SCHEMBL5923917 0.71 MAPT (0.67) USP2NPC1NFKB1RAB9ANFKB2
SCHEMBL7082838 0.71 HTR2C (0.70) HTR2CNPC1RAB9AHTR2ACYP1A2
SCHEMBL7082664 0.69 HTR2C (0.62) HTR2CNPC1NFKB1RAB9ANFKB2
SCHEMBL9035888 0.69 HTR2C (1.00) HTR2CNPC1NFKB1RAB9ANFKB2
SCHEMBL25112365 0.67 USP2 (0.57) USP2HTR2CNPC1NFKB1RAB9A
SCHEMBL12692437 0.67 NPC1 (1.00) USP2HTR2CNPC1NFKB1RAB9A
SCHEMBL16344647 0.65 ROCK2 (1.00) HTR2CROCK2
SCHEMBL28367564 0.65 NPC1 (1.00) USP2HTR2CNPC1NFKB1RAB9A
SCHEMBL8526790 0.65 HTR2C (1.00) HTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808312-A1 INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 1997-11-26 EP claimed
WO-2003011281-A1 TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER OR ATTENTION DEFICIT DISORDER VERNALIS RESEARCH LIMITED (GB) 2003-02-13 WO disclosed
EP-0808312-A1 INDOLE DERIVATIVES AS 5-HT RECEPTOR ANTAGONIST SMITHKLINE BEECHAM PLC (GB) 1997-11-26 EP disclosed